BLRX
BioLineRX
BLRX
BLRX
28 hedge funds and large institutions have $43.4M invested in BioLineRX in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more ownership
Funds ownership: 0.06% → 0.06% (+0%)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
Holders
28
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$9.51M | |
| 2 | +$1.44M | |
| 3 | +$303K | |
| 4 |
Morgan Stanley
New York
|
+$112K |
| 5 |
MCC
Malaga Cove Capital
Pv Estates,
California
|
+$38.4K |
Top Sellers
| 1 | -$2.51M | |
| 2 | -$828K | |
| 3 | -$743K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$126K |
| 5 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
-$117K |